|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23.56 EUR | +2.43% |
|
+6.61% | +2.52% |
| Jan. 09 | Case Closed: No Further Action in Italian Investigation Against Verallia | |
| Jan. 08 | Verallia acknowledges Italian competition authority's decision confirming compliance with competition laws | RE |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
Profitability | |||||||||
Return on Assets | 7.64 | 7.98 | 9.53 | 11.66 | 7.46 | ||||
Return on Total Capital | 11.12 | 11.65 | 14.59 | 18.48 | 11.05 | ||||
Return On Equity % | 42.03 | 36.2 | 38.09 | 46.92 | 23.56 | ||||
Return on Common Equity | 43.72 | 37.77 | 39.09 | 49.18 | 24.75 | ||||
Margin Analysis | |||||||||
Gross Profit Margin % | 22.39 | 23.62 | 24.6 | 26.9 | 20.74 | ||||
SG&A Margin | 6.38 | 6.54 | 5.8 | 5.52 | 4.97 | ||||
EBITDA Margin % | 26.01 | 26.77 | 27.58 | 29.66 | 26.01 | ||||
EBITA Margin % | 18.41 | 19.34 | 18.8 | 21.39 | 15.77 | ||||
EBIT Margin % | 16.01 | 17.08 | 18.8 | 21.39 | 15.77 | ||||
Income From Continuing Operations Margin % | 8.27 | 9.32 | 10.61 | 12.18 | 6.9 | ||||
Net Income Margin % | 7.97 | 9.07 | 10.2 | 12.04 | 6.82 | ||||
Net Avail. For Common Margin % | 7.97 | 9.07 | 10.2 | 12.04 | 6.82 | ||||
Normalized Net Income Margin | 8.82 | 9.7 | 10.46 | 12.04 | 8.16 | ||||
Levered Free Cash Flow Margin | 13.15 | 5.62 | 11.91 | 17.45 | -1.65 | ||||
Unlevered Free Cash Flow Margin | 14.06 | 6.34 | 12.39 | 18.5 | -0.18 | ||||
Asset Turnover | |||||||||
Asset Turnover | 0.76 | 0.75 | 0.81 | 0.87 | 0.76 | ||||
Fixed Assets Turnover | 1.96 | 2.03 | 2.26 | 2.29 | 1.84 | ||||
Receivables Turnover (Average Receivables) | 23.7 | 24.21 | 18.02 | 19.78 | 21.63 | ||||
Inventory Turnover (Average Inventory) | 4.67 | 5.16 | 5.37 | 4.57 | 3.81 | ||||
Short Term Liquidity | |||||||||
Current Ratio | 1.16 | 1.28 | 1.03 | 0.91 | 1.05 | ||||
Quick Ratio | 0.68 | 0.62 | 0.45 | 0.41 | 0.49 | ||||
Operating Cash Flow to Current Liabilities | 0.69 | 0.61 | 0.47 | 0.53 | 0.41 | ||||
Days Sales Outstanding (Average Receivables) | 15.44 | 15.08 | 20.26 | 18.45 | 16.92 | ||||
Days Outstanding Inventory (Average Inventory) | 78.3 | 70.7 | 67.96 | 79.84 | 96.1 | ||||
Average Days Payable Outstanding | 72.35 | 78.76 | 86.6 | 82.43 | 80.89 | ||||
Cash Conversion Cycle (Average Days) | 21.39 | 7.02 | 1.62 | 15.86 | 32.13 | ||||
Long Term Solvency | |||||||||
Total Debt/Equity | 303.7 | 220.86 | 165.18 | 194.02 | 213.62 | ||||
Total Debt / Total Capital | 75.23 | 68.83 | 62.29 | 65.99 | 68.11 | ||||
LT Debt/Equity | 271.56 | 196.2 | 146.36 | 168.02 | 176.71 | ||||
Long-Term Debt / Total Capital | 67.27 | 61.15 | 55.19 | 57.15 | 56.35 | ||||
Total Liabilities / Total Assets | 82.68 | 79.05 | 75.97 | 78.51 | 77.18 | ||||
EBIT / Interest Expense | 7.32 | 9.44 | 11.8 | 9.44 | 5.02 | ||||
EBITDA / Interest Expense | 12.22 | 15.15 | 17.31 | 13.1 | 8.28 | ||||
(EBITDA - Capex) / Interest Expense | 7.84 | 9.91 | 10.47 | 8.43 | 5.36 | ||||
Total Debt / EBITDA | 2.59 | 2.41 | 1.91 | 1.61 | 2.54 | ||||
Net Debt / EBITDA | 1.89 | 1.73 | 1.55 | 1.2 | 2.01 | ||||
Total Debt / (EBITDA - Capex) | 4.03 | 3.68 | 3.15 | 2.5 | 3.91 | ||||
Net Debt / (EBITDA - Capex) | 2.94 | 2.65 | 2.56 | 1.86 | 3.11 | ||||
Growth Over Prior Year | |||||||||
Total Revenues, 1 Yr. Growth % | -1.93 | 5.45 | 25.34 | 16.48 | -11.47 | ||||
Gross Profit, 1 Yr. Growth % | 4.68 | 11.26 | 30.53 | 27.4 | -31.76 | ||||
EBITDA, 1 Yr. Growth % | 3.32 | 5.23 | 25.2 | 25.41 | -22.35 | ||||
EBITA, 1 Yr. Growth % | 12.08 | 10.92 | 37.64 | 32.8 | -34.73 | ||||
EBIT, 1 Yr. Growth % | 14.37 | 12.49 | 37.64 | 32.8 | -34.73 | ||||
Earnings From Cont. Operations, 1 Yr. Growth % | 68.22 | 18.94 | 42.64 | 33.66 | -49.8 | ||||
Net Income, 1 Yr. Growth % | 74.83 | 20.04 | 40.97 | 37.43 | -49.85 | ||||
Normalized Net Income, 1 Yr. Growth % | 38.61 | 15.98 | 35.19 | 33.96 | -39.94 | ||||
Diluted EPS Before Extra, 1 Yr. Growth % | 67 | 20.36 | 45.19 | 37.41 | -50.12 | ||||
Accounts Receivable, 1 Yr. Growth % | -13.43 | 22.46 | 105.92 | -42.37 | 21.48 | ||||
Inventory, 1 Yr. Growth % | -15 | 4.5 | 32.77 | 32.54 | 2.18 | ||||
Net Property, Plant and Equip., 1 Yr. Growth % | -0.83 | 4.86 | 19.09 | 11.6 | 8.97 | ||||
Total Assets, 1 Yr. Growth % | 0.96 | 14.42 | 16.4 | -0.71 | 4.82 | ||||
Tangible Book Value, 1 Yr. Growth % | -36.39 | -63.06 | -40 | 37.13 | -34.93 | ||||
Common Equity, 1 Yr. Growth % | 39.38 | 38.66 | 34.43 | -9.52 | 9.79 | ||||
Cash From Operations, 1 Yr. Growth % | 22.71 | 5.23 | 8.99 | 22.7 | -31.51 | ||||
Capital Expenditures, 1 Yr. Growth % | -3.88 | 1.04 | 40.57 | 12.48 | -24.31 | ||||
Levered Free Cash Flow, 1 Yr. Growth % | 13.71 | -54.63 | 164.62 | 71.38 | -108.38 | ||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 6.19 | -52.14 | 144.23 | 74.53 | -100.88 | ||||
Dividend Per Share, 1 Yr. Growth % | 11.76 | 10.53 | 33.81 | 53.57 | -20.93 | ||||
Compound Annual Growth Rate Over Two Years | |||||||||
Total Revenues, 2 Yr. CAGR % | 2.46 | 1.69 | 14.96 | 20.83 | 1.55 | ||||
Gross Profit, 2 Yr. CAGR % | 13.25 | 7.92 | 20.51 | 28.95 | -6.76 | ||||
EBITDA, 2 Yr. CAGR % | 3.94 | 5.87 | 16.59 | 25.22 | -1.32 | ||||
EBITA, 2 Yr. CAGR % | 12.26 | 11.44 | 16.24 | 35.06 | -6.9 | ||||
EBIT, 2 Yr. CAGR % | 14.66 | 13.42 | 24.57 | 35.06 | -6.9 | ||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 107.89 | 41.45 | 30.25 | 38.08 | -18.09 | ||||
Net Income, 2 Yr. CAGR % | 121.75 | 44.87 | 30.09 | 39.19 | -16.98 | ||||
Normalized Net Income, 2 Yr. CAGR % | 38.62 | 26.79 | 25.21 | 34.57 | -10.3 | ||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 115.78 | 41.77 | 32.19 | 41.25 | -17.22 | ||||
Accounts Receivable, 2 Yr. CAGR % | -8.8 | 2.96 | 58.8 | 8.93 | -16.33 | ||||
Inventory, 2 Yr. CAGR % | -10.02 | -5.76 | 17.79 | 32.66 | 16.38 | ||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 3.64 | 1.97 | 11.75 | 15.28 | 10.28 | ||||
Total Assets, 2 Yr. CAGR % | -0.18 | 7.48 | 15.4 | 8.1 | 2.02 | ||||
Tangible Book Value, 2 Yr. CAGR % | -37.7 | -51.53 | -52.92 | 12.12 | -5.54 | ||||
Common Equity, 2 Yr. CAGR % | 382.73 | 39.02 | 36.53 | 10.29 | -0.33 | ||||
Cash From Operations, 2 Yr. CAGR % | 19.16 | 13.63 | 7.1 | 15.64 | -8.33 | ||||
Capital Expenditures, 2 Yr. CAGR % | 3.86 | 0.2 | 20.65 | 26.05 | -7.15 | ||||
Levered Free Cash Flow, 2 Yr. CAGR % | 11.35 | -28.39 | 9.73 | 112.52 | -62.09 | ||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 5.38 | -28.91 | 8.25 | 106.06 | -87.62 | ||||
Dividend Per Share, 2 Yr. CAGR % | - | 11.14 | 21.61 | 43.1 | 10.19 | ||||
Compound Annual Growth Rate Over Three Years | |||||||||
Total Revenues, 3 Yr. CAGR % | 1.91 | 3.44 | 9.03 | 15.47 | 8.93 | ||||
Gross Profit, 3 Yr. CAGR % | 11.08 | 12.58 | 14.98 | 22.76 | 4.3 | ||||
EBITDA, 3 Yr. CAGR % | 3.8 | 5.44 | 13.13 | 19.4 | 6.78 | ||||
EBITA, 3 Yr. CAGR % | 12.26 | 11.77 | 14.79 | 21.43 | 5.99 | ||||
EBIT, 3 Yr. CAGR % | 15.01 | 13.93 | 21.07 | 27.17 | 5.99 | ||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 153.28 | 72.58 | 41.85 | 31.38 | -1.45 | ||||
Net Income, 3 Yr. CAGR % | 351.21 | 80.72 | 43.56 | 32.49 | -0.96 | ||||
Normalized Net Income, 3 Yr. CAGR % | 42.81 | 30.62 | 29.53 | 28.07 | 2.84 | ||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 343.08 | 77.63 | 42.9 | 33.91 | -0.17 | ||||
Accounts Receivable, 3 Yr. CAGR % | -10.22 | 0.61 | 29.72 | 13.27 | 12.97 | ||||
Inventory, 3 Yr. CAGR % | -6.02 | -5.42 | 5.65 | 22.52 | 21.6 | ||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 2.15 | 4.05 | 7.39 | 11.7 | 13.14 | ||||
Total Assets, 3 Yr. CAGR % | -0.68 | 4.47 | 10.37 | 10.17 | 6.99 | ||||
Tangible Book Value, 3 Yr. CAGR % | -29.02 | -47.66 | -47.95 | -22.56 | -6.48 | ||||
Common Equity, 3 Yr. CAGR % | 400.25 | 218.51 | 37.47 | 19.03 | 10.12 | ||||
Cash From Operations, 3 Yr. CAGR % | 12.76 | 14.33 | 12.07 | 12.06 | -2.88 | ||||
Capital Expenditures, 3 Yr. CAGR % | 0.98 | 4.06 | 13.09 | 18.05 | 6.79 | ||||
Levered Free Cash Flow, 3 Yr. CAGR % | 13.46 | -17.62 | 10.82 | 27.14 | -27.65 | ||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 7.3 | -19.15 | 7.36 | 26.77 | -66.6 | ||||
Dividend Per Share, 3 Yr. CAGR % | - | - | 18.24 | 31.29 | 17.42 | ||||
Compound Annual Growth Rate Over Five Years | |||||||||
Total Revenues, 5 Yr. CAGR % | - | 3.15 | 6.94 | 10.07 | 5.97 | ||||
Gross Profit, 5 Yr. CAGR % | - | 10.51 | 14.76 | 18.87 | 5.74 | ||||
EBITDA, 5 Yr. CAGR % | - | 9.1 | 9.4 | 13.65 | 7.08 | ||||
EBITA, 5 Yr. CAGR % | - | 15.79 | 13.81 | 17.65 | 5.52 | ||||
EBIT, 5 Yr. CAGR % | - | 19.65 | 18.74 | 22.01 | 8.95 | ||||
Earnings From Cont. Operations, 5 Yr. CAGR % | - | 55.98 | 94.12 | 57.85 | 13.88 | ||||
Net Income, 5 Yr. CAGR % | - | 44.96 | 174.36 | 62.8 | 15.31 | ||||
Normalized Net Income, 5 Yr. CAGR % | - | 129.92 | 35.49 | 32.19 | 11.82 | ||||
Diluted EPS Before Extra, 5 Yr. CAGR % | - | 42.67 | 173.13 | 62.07 | 14.87 | ||||
Accounts Receivable, 5 Yr. CAGR % | - | -6.6 | 12.79 | 3.86 | 8.85 | ||||
Inventory, 5 Yr. CAGR % | - | -3.58 | 2.86 | 8.28 | 9.82 | ||||
Net Property, Plant and Equip., 5 Yr. CAGR % | - | 1.24 | 5.89 | 8.4 | 8.53 | ||||
Total Assets, 5 Yr. CAGR % | - | 1.14 | 5.46 | 5.91 | 7.19 | ||||
Tangible Book Value, 5 Yr. CAGR % | - | -33.76 | -39.77 | -29.02 | -28.1 | ||||
Common Equity, 5 Yr. CAGR % | - | 78.93 | 197.58 | 108.39 | 20.88 | ||||
Cash From Operations, 5 Yr. CAGR % | - | 9.13 | 10.46 | 14.85 | 3.41 | ||||
Capital Expenditures, 5 Yr. CAGR % | - | 1.13 | 9.15 | 12.9 | 4.62 | ||||
Levered Free Cash Flow, 5 Yr. CAGR % | - | - | 11.82 | 20.42 | -27.91 | ||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | - | - | 7.56 | 17.6 | -54.79 | ||||
Dividend Per Share, 5 Yr. CAGR % | - | - | - | - | 14.87 |
- Stock Market
- Equities
- VRLA Stock
- Financials Verallia
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















